611 related articles for article (PubMed ID: 27351131)
1. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Shang R; Pu M; Li Y; Wang D
Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
Teng Y; Zhang Y; Qu K; Yang X; Fu J; Chen W; Li X
Oncotarget; 2015 Dec; 6(38):40799-814. PubMed ID: 26512921
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
7. Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.
Zou J; Wang Y; Liu M; Huang X; Zheng W; Gao Q; Wang H
Cell Biochem Funct; 2018 Aug; 36(6):303-311. PubMed ID: 29984416
[TBL] [Abstract][Full Text] [Related]
8. MFAP2 aggravates tumor progression through activating FOXM1/β-catenin-mediated glycolysis in ovarian cancer.
Zhao LQ; Sun W; Zhang P; Gao W; Fang CY; Zheng AW
Kaohsiung J Med Sci; 2022 Aug; 38(8):772-780. PubMed ID: 35546486
[TBL] [Abstract][Full Text] [Related]
9. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.
Kuai XY; Lei ZY; Liu XS; Shao XY
Anticancer Agents Med Chem; 2020; 20(8):941-950. PubMed ID: 32188390
[TBL] [Abstract][Full Text] [Related]
10. Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma.
Li Q; Qin Y; Wei P; Lian P; Li Y; Xu Y; Li X; Li D; Cai S
Mol Cancer Res; 2016 Sep; 14(9):830-40. PubMed ID: 27401611
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
14. BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells.
An MX; Li S; Yao HB; Li C; Wang JM; Sun J; Li XY; Meng XN; Wang HQ
J Cell Biol; 2017 Dec; 216(12):4091-4105. PubMed ID: 29114069
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer.
Wen N; Wang Y; Wen L; Zhao SH; Ai ZH; Wang Y; Wu B; Lu HX; Yang H; Liu WC; Li Y
J Transl Med; 2014 May; 12():134. PubMed ID: 24885308
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Yoon SO; Jeon TJ; Park JS; Ryu YH; Lee JH; Yoo JS; Kim JK; Yoon DS; Oh EJ
Clin Nucl Med; 2015 Mar; 40(3):e178-82. PubMed ID: 25608150
[TBL] [Abstract][Full Text] [Related]
17. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.
Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B
Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
19. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z
Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130
[TBL] [Abstract][Full Text] [Related]
20. HNRNPC Regulates GLUT1/LDHA Pathway by Stabilizing FOXM1 mRNA to Promote the Progression and Aerobic Glycolysis of Multiple Myeloma.
Wu N; Zhu Y
Ann Clin Lab Sci; 2024 Jan; 54(1):56-65. PubMed ID: 38514068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
